Curaleaf has over 550 million shares, and is trading at 12 bucks now ($8 billion market cap). It comes down to ensuring investors that their money is going in the right places, and revenue growth for years. Marimed did fine at first, but then made a series of poor investments, paid for with shares, which lead to the tumble in price. Those investments have been written off, and the company is finally making a profit. The market will wake up to MRMD soon again. I averaged down from 83 cents, and am feeling good about the direction we're heading long-term. 46k shares at 12 bucks would be a pretty chunk of change. In time, of course...
News 
Market Data 
Discover 
